ReviewFrontiers in endocrinology2025
Malignant melanoma with pituitary metastasis: A case report and literature review.
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: A case of superficial spreading malignant melanoma with sentinel lymph node metastasis misdiagnosed as "pigmented nevus".Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Pituitary metastasis of malignant melanoma (MM) is rare. This study aimed to explore its diagnostic features using a multimodal approach and retrospectively analyzed previously reported cases to summarize its pathogenesis and diagnostic challenges. Methods: We screened all published case reports and case series on pituitary metastatic MM using PubMed, focusing on cases with detailed clinical data, imaging features, pathological examination, and molecular test results. A total of 24 cases of MM with pituitary metastasis, including our case, were retrospectively analyzed. Additionally, the index patient underwent histopathological, immunohistochemical (S100, SOX10, Melan-A, HMB-45, Results: This case involved a 65-year-old female patient whose pathological examination revealed tumor cells with epithelioid and spindle cell features. Immunohistochemical analysis showed diffuse positivity for S-100, vimentin, and Conclusion: Diagnosing MM with pituitary metastasis requires integrating detailed clinical history, imaging features, pathological examination, and molecular testing. Our findings highlight the importance of a comprehensive diagnostic approach with multidisciplinary collaboration when managing atypical pituitary masses, along with detailed investigation of a patient's previous tumor history, to improve diagnostic accuracy and patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.